UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma

Leukemia, 2008-07, Vol.22 (7), p.1419-1427

2008

Volltextzugriff (PDF)

Clinical feasibility of TBI with helical tomotherapy

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.929-935

2011

Volltextzugriff (PDF)

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (8), p.823-828

2004

Volltextzugriff (PDF)

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

Bone marrow transplantation (Basingstoke), 2006-10, Vol.38 (7), p.501-506

2006

Volltextzugriff (PDF)

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.389-396

2004

Volltextzugriff (PDF)

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Leukemia, 2008-08, Vol.22 (8), p.1633-1636

2008

Volltextzugriff (PDF)

Suppression of abnormal karyotype predicts superior survival in multiple myeloma

Leukemia, 2008-04, Vol.22 (4), p.850-855

2008

Volltextzugriff (PDF)

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2006-02, Vol.37 (4), p.403-409

2006

Volltextzugriff (PDF)

Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (5), p.511-515

2006

Volltextzugriff (PDF)

Role of quantitative human cytomegalovirus PCR in predicting antiviral treatment response among high-risk hematopoietic stem-cell transplant recipients

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.463-464

2004

Volltextzugriff (PDF)

P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease

European neuropsychopharmacology, 2015-09, Vol.25, p.S403-S404

2015

Volltextzugriff (PDF)

Treatment of Idiopathic Castleman Disease

Hematology/oncology clinics of North America, 2018-02, Vol.32 (1), p.89-106

2018

Volltextzugriff (PDF)

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives

OncoTargets and therapy, 2023-01, Vol.16, p.441-464

2023

Volltextzugriff (PDF)

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Leukemia, 2008-08, Vol.22 (8), p.1650-1650

2008

Volltextzugriff (PDF)

DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2732-2739

2003

Volltextzugriff (PDF)

High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vector

Human gene therapy, 2003-09, Vol.14 (14), p.1333-1345

2003

Volltextzugriff (PDF)

Profile of elotuzumab and its potential in the treatment of multiple myeloma

Blood and lymphatic cancer, 2014-06, Vol.2014 (4), p.15-27

2014

Volltextzugriff (PDF)

Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?

Nature clinical practice. Oncology, 2008-02, Vol.5 (2), p.70-71

van Rhee, Frits

2008

Volltextzugriff (PDF)

Donor leukocyte transfusions for leukemic relapse

Current opinion in hematology, 1995, Vol.2 (6), p.423-430

1995

Volltextzugriff (PDF)

The Role of Plasma Cytokines in the Diagnosis of Autoimmune Phenomena in Patients (pts) With Multiple Myeloma (MM) Undergoing Novel Anti-Myeloma Therapies and Autologous Hematopoietic Cell Transplantation (auto-HCT)

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S347-S348

2011

Volltextzugriff (PDF)

PSY52 DEVELOPMENT AND CONTENT VALIDATION OF A MULTICENTRIC CASTLEMANS DISEASE SYMPTOM SCALE

Value in health, 2010, Vol.13 (7), p.A470-A470

2010

Volltextzugriff (PDF)

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

Experimental hematology, 2003, Vol.31 (1), p.73-80

2003

Volltextzugriff (PDF)

Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma

Journal of immunotherapy, 2007-11, Vol.30 (8), p.847-854

2007

Volltextzugriff (PDF)

In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation

Journal of immunotherapy (1997), 2001-07, Vol.24 (4), p.312-322

2001

Volltextzugriff (PDF)

Efficacy Of Plerixafor Plus G-CSF In Hematopoietic Stem Cell (HSC) Remobilization In Patients With Amyloidosis

Biology of blood and marrow transplantation, 2010, Vol.16 (2), p.S203-S204

2010

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma

Clinical feasibility of TBI with helical tomotherapy

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Suppression of abnormal karyotype predicts superior survival in multiple myeloma

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation

Role of quantitative human cytomegalovirus PCR in predicting antiviral treatment response among high-risk hematopoietic stem-cell transplant recipients

P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease

Treatment of Idiopathic Castleman Disease

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma

High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vector

Profile of elotuzumab and its potential in the treatment of multiple myeloma

Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?

Donor leukocyte transfusions for leukemic relapse

The Role of Plasma Cytokines in the Diagnosis of Autoimmune Phenomena in Patients (pts) With Multiple Myeloma (MM) Undergoing Novel Anti-Myeloma Therapies and Autologous Hematopoietic Cell Transplantation (auto-HCT)

PSY52 DEVELOPMENT AND CONTENT VALIDATION OF A MULTICENTRIC CASTLEMANS DISEASE SYMPTOM SCALE

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma

In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation

Efficacy Of Plerixafor Plus G-CSF In Hematopoietic Stem Cell (HSC) Remobilization In Patients With Amyloidosis

Aktive Filter

Suchergebnisse filtern